Personalized medicine for individuals with Down syndrome

被引：4
|
作者：
McCabe, Linda L. [1 ,2 ,3 ]
McCabe, Edward R. B. [1 ,3 ]
机构：
[1] Univ Colorado, Sch Med, Linda Crnic Inst Syndrome, Aurora, CO 80045 USA
[2] Univ Colorado, Sch Med, Ctr Bioeth & Humanities, Aurora, CO 80045 USA
[3] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2011年 / 104卷 / 1-2期
关键词：
Down syndrome; Personalized medicine; SIMPLE MENDELIAN DISORDERS; DOCK8;
D O I：
10.1016/j.ymgme.2011.07.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
As the cost of whole genome analysis decreases, we have the opportunity to explore the interactions of various gene changes in an individual that lead to their particular phenotype. This will provide the ability to move from the epidemiologic study of groups, in which, the individuals are treated collectively and homogenously, to personalized medicine, and a model in which the individual is recognized and treated as a distinct entity. We will be applying personalized medicine to individuals with Down syndrome in order to understand and develop biomarkers for increased risk of co-morbidities. Personalized medicine will change the "culture of intractability" of Down syndrome. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码：7 / 9
页数：3
相关论文
共 50 条
  • [21] Economy of Pedaling in Individuals With Down Syndrome
    Guerra, Myriam
    Garrido, Eduardo
    Carmen Martin-Borras, Ma
    Gine-Garriga, Maria
    Oviedo, Guillermo
    Fernhall, Bo
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2012, 44 : 406 - 406
  • [22] Memory coding in individuals with Down syndrome
    Lanfranchi, Silvia
    Toffanin, Elena
    Zilli, Simona
    Panzeri, Benedetta
    Vianello, Renzo
    [J]. CHILD NEUROPSYCHOLOGY, 2014, 20 (06) : 700 - 712
  • [23] Pharmacotherapeutic Considerations for Individuals with Down Syndrome
    Hefti, Erik
    Blanco, Javier G.
    [J]. PHARMACOTHERAPY, 2017, 37 (02): : 214 - 220
  • [24] Verb use by individuals with Down syndrome
    Hesketh, LJ
    Chapman, RS
    [J]. AMERICAN JOURNAL ON MENTAL RETARDATION, 1998, 103 (03): : 288 - 304
  • [25] Language and communication in individuals with Down syndrome
    Chapman, RS
    [J]. INTERNATIONAL REVIEW OF RESEARCH IN MENTAL RETARDATION, VOL 27: LANGUAGE AND COMMUNICATION IN MENTAL RETARDATION, 2003, 27 : 1 - 34
  • [26] Cancer risk in individuals with Down syndrome
    [J]. European Journal of Pediatrics, 2000, 159 (6) : b470 - b471
  • [27] Presenility of granulocytes in Down syndrome individuals
    Yasui, K
    Shinozaki, K
    Nakazawa, T
    Agematsu, K
    Komiyama, A
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 84 (05): : 406 - 412
  • [28] Behavioral phenotype of individuals with Down syndrome
    Chapman, RS
    Hesketh, LJ
    [J]. MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2000, 6 (02): : 84 - 95
  • [29] Memory and language in individuals with Down syndrome and Williams syndrome
    Vicari, S
    Reilly, J
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2000, 44 : 504 - 504
  • [30] PERSONALIZED MEDICINE FOR GUILLAIN-BARRE SYNDROME
    Jacobs, B. C.
    [J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 88 - 89
12345